Related Experiment Video
Updated: Apr 26, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Reduction in dynamin-2 is implicated in ischaemic cardiac arrhythmias
Dan Shi1, Duanyang Xie, Hong Zhang
1Key Laboratory of Basic Research in Cardiology of the Ministry of Education of China, Tongji University, Shanghai, China; Institute of Medical Genetics, Tongji University, Shanghai, China.
Dynamin-2 (DNM2) reduction worsens cardiac arrhythmias during ischemia by disrupting ion channel function. Targeting DNM2 may offer new antiarrhythmic therapies for sudden cardiac death.
Area of Science:
- Cardiology
- Molecular Biology
- Biophysics
Background:
- Ischaemic cardiac arrhythmias are a major cause of sudden cardiac death worldwide.
- Sarcolemma ion channel dysfunction is a key mechanism in ischaemic arrhythmogenesis.
- Regulators of ion channel turnover during ischaemia are largely unknown.
Purpose of the Study:
- To investigate the role of dynamin-2 (DNM2) in acute ischaemic cardiac arrhythmias.
- To elucidate the mechanisms by which DNM2 affects ion channel function and trafficking in cardiomyocytes.
- To explore DNM2 as a potential therapeutic target for antiarrhythmic strategies.
Main Methods:
- Analysis of DNM2 protein and transcription levels in rat ventricular tissues and cardiomyocytes under acute ischaemic stress.
- Electrophysiological studies to assess action potential characteristics.
- Investigation of sarcolemma ion channel (Nav1.5, Kir2.1) trafficking using cellular and molecular techniques.
Main Results:
- DNM2 protein and transcription levels were significantly down-regulated in response to acute ischaemic stress.
- Reduced DNM2 levels correlated with severe ventricular arrhythmias.
- DNM2 down-regulation impaired retrograde trafficking of Nav1.5 and Kir2.1 channels, increasing action potential amplitude and prolonging repolarization.
Conclusions:
- DNM2 plays a critical role in regulating sarcolemma ion channel trafficking and function during cardiac ischaemia.
- Down-regulation of DNM2 contributes to arrhythmogenesis by altering cardiomyocyte electrophysiology.
- DNM2 represents a potential therapeutic target for developing novel antiarrhythmic drugs.
More Related Videos
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers